These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Polypill strategy vs. prevention clinics for stroke prevention. Amarenco P Cerebrovasc Dis; 2006; 21 Suppl 1():35-40. PubMed ID: 16479100 [TBL] [Abstract][Full Text] [Related]
43. [Risk factor, natural history and prognosis of the patients with arteriosclerosis obliterans]. Ito M; Mishima Y Nihon Geka Gakkai Zasshi; 1996 Jul; 97(7):476-80. PubMed ID: 8808807 [TBL] [Abstract][Full Text] [Related]
44. [Peripheral arterial disease with lower limb claudication: Medical treatment]. Long A; Bui HT; Journet J; Hadj Henni A J Mal Vasc; 2009 Nov; 34(5):323-9. PubMed ID: 19713062 [TBL] [Abstract][Full Text] [Related]
45. Reducing the cardiovascular disease burden: justified means for getting to the end. Bikdeli B; Barreto-Filho JA Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):580-6. PubMed ID: 22811501 [No Abstract] [Full Text] [Related]
46. Cost implications of new evidence on prevention of cardiovascular disease. Kaplan RC; Schechter C Expert Rev Pharmacoecon Outcomes Res; 2005 Apr; 5(2):183-92. PubMed ID: 19807573 [TBL] [Abstract][Full Text] [Related]
51. Cardiovascular risk management in diabetes in primary care. Kalra S; Gupta Y J Pak Med Assoc; 2015 Aug; 65(8):907-8. PubMed ID: 26228345 [TBL] [Abstract][Full Text] [Related]
52. Effective and safe modification of multiple atherosclerotic risk factors in patients with peripheral arterial disease. Garg R; Elam MB; Crouse JR; Davis KB; Kennedy JW; Egan D; Herd JA; Hunninghake DB; Johnson WC; Kostis JB; Sheps DS; Applegate WB Am Heart J; 2000 Nov; 140(5):792-803. PubMed ID: 11054628 [TBL] [Abstract][Full Text] [Related]
53. [Problems of arteriosclerosis epidemiology. Analysis of risk factors with a view to a possible therapy]. Prof Aiuto G Minerva Med; 1976 Dec; 67(62):4059-118. PubMed ID: 1018807 [No Abstract] [Full Text] [Related]
55. [Arteriosclerosis obliterans (ASO)]. Koshikawa M; Ikeda U Nihon Rinsho; 2010 May; 68(5):926-9. PubMed ID: 20446594 [TBL] [Abstract][Full Text] [Related]
56. [Hypertension and arteriosclerosis. Correlations and prospects of preventive therapy]. Caruzzo C; Salto A; Pozzallo G; Dalmasso M; Casaccia M Minerva Cardioangiol; 1976 Jun; 24(6):444-52. PubMed ID: 1012493 [No Abstract] [Full Text] [Related]
57. Pharmacological treatment of patients with peripheral arterial disease. Kim CK; Schmalfuss CM; Schofield RS; Sheps DS Drugs; 2003; 63(7):637-47. PubMed ID: 12656644 [TBL] [Abstract][Full Text] [Related]
58. [Garlic therapy? Theories of a folk remedy (author's transl)]. Ernst E MMW Munch Med Wochenschr; 1981 Oct; 123(41):1537-8. PubMed ID: 6795467 [TBL] [Abstract][Full Text] [Related]
59. [Current progress in the treatment for diabetic retinopathy in internal medicine]. Hamada Y Nihon Rinsho; 2002 Oct; 60 Suppl 10():173-7. PubMed ID: 12430225 [No Abstract] [Full Text] [Related]
60. The prevention of cardiovascular disease. Emphasis on secondary prevention. Robinson JG; Leon AS Med Clin North Am; 1994 Jan; 78(1):69-98. PubMed ID: 8283936 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]